Medicinal Chemistry · 2018 · 15 citations · 48 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignStructure-activity RelationshipsOncology PharmacologyStructure-activity Relationship AnalysisActivitiesAnticancer ActivityAnticancer Compound ScreeningBiological Activity FeaturesBiological Evaluation ReportChemical Structure-activity RelationshipsMedicinal Chemistry ApplicationsReactive Oxygen Species Generation
BACKGROUND: Low molecular weight 1,2,3-triazoles and naphthoquinones are endowed with various types of biological activity, such as against cancer, HIV and bacteria. However, in some cases, the conjugation of these two nuclei considerably increases their biological activities. OBJECTIVE: In this work, we decided to study the synthesis and screening of bis-naphthoquinones and xanthenes tethered to 1,2,3-triazoles against cancer cell lines, specifically the human breast cancer cell line MCF-7. RESULTS: Starting from lawsone and aryl-1H-1,2,3-triazole-4-carbaldehydes (10a-h) several new 7- (1-aryl-1H-1,2,3-triazol-4-yl)-6H-dibenzo[b,h]xanthene-5,6,8,13(7H)-tetraones (12a-h) and 3,3'- ((1-aryl-1H-1,2,3-triazol-4-yl)methylene)bis(2-hydroxynaphthalene-1,4-diones) 11a-h were synthesized and evaluated for their cytotoxic activities using the human breast cancer cell line MCF-7 and the non-tumor cell line MCF10A as control. We performed test of cell viability, cell proliferation, intracellular ATP content and cell cytometry to determine reactive oxygen species (ROS) formation. CONCLUSIONS: Based on these results, we found that compound 12a promotes ROS production, interfering with energy metabolism, cell viability and proliferation, and thus promoting whole cell damage.
48
Laurence Salmon-Chemin, Eric Buisine, Vanessa Yardley et al. · Journal of Medicinal Chemistry · 2001 · 257 citations · Full text
Gordon W. Rewcastle, Graham J. Atwell, Li Zhuang et al. · Journal of Medicinal Chemistry · 1991 · 194 citations